Product code QLG— Clinical Chemistry

FreeStyle Libre 2 Flash Glucose Monitoring System

Classification name
Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems
Device class
Class 2
Regulation
21 CFR 862.1355
Advisory panel
Clinical Chemistry
Total cleared
9
First cleared
Most recent

FDA classification definition

“An integrated continuous glucose monitoring system for replacement of finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes, unless otherwise indicated. The system automatically measures glucose in bodily fluids continuously or frequently for a specified period of time. The system is also designed to reliably and securely transmit glucose measurement data to digitally connected devices and are intended to be used alone or in conjunction with these digitally connected devices where the user manually controls actions for therapy decisions. The system is not intended to be used with automated insulin dosing (AID) systems.”

— U.S. Food and Drug Administration, device classification record for product code QLG under 21 CFR 862.1355, via openFDA

Market context for product code QLG

FDA has cleared 9 devices under product code QLG between 2020 and 2023, filed by 2 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

Top applicants under product code QLG

Adverse events under product code QLG

product code QLG
Death
27
Injury
40,773
Malfunction
107,857
Other
6
Total
148,663

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recent clearances under product code QLG

Data sourced from openFDA. This site is unofficial and independent of the FDA.